Pain, Postoperative Arthroscopy
Conditions
Brief summary
Study the effect of rofecoxib 50 mg compared to both placebo, and hydrocodone 7.5 mg with acetaminophen 750 mg, to treat moderate to severe pain following arthroscopic knee surgery.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Elective outpatient arthroscopic knee surgery expected to last \<= 90 minutes using general anesthesia * Patients must experience moderate to severe pain following surgery * Patient must be in general good health as judged by the primary investigator
Exclusion criteria
* Osteoarthritis; rheumatoid arthritis * Allergy/sensitivity to aspirin, ibuprofen, indomethacin, other NSAIDs, COX-2 inhibitors (e.g., rofecoxib, celecoxib), hydrocodone, acetaminophen * Asthma associated with nasal polyps * Any arthroscopic knee surgery in the past 6 months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total Pain Relief over 6 hours following a single oral dose compared to placebo. | 6 hours |
Secondary
| Measure | Time frame |
|---|---|
| Total Pain Relief over 6 hours following a single oral dose compared to hydrocodone + acetaminophen. | 6 hours |